4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-23-021284
Options or other derivatives
- VP and Chief Compliance Office acquired 4,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Herman James L VP and Chief Compliance Office | 2023-03-24 | Grant or award · Options (right to buy) | +4,000 | 12,000 | D | ||
Loading xslF345X04/doc4.xml…